ClinicalTrials.Veeva

Menu

Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)

Samsung Medical Center logo

Samsung Medical Center

Status

Enrolling

Conditions

Heart Failure

Treatments

Diagnostic Test: Device interrogation

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04397224
2018-05-073

Details and patient eligibility

About

This prospective multicenter registry study aims to detect the serial changes in ventriculo-ventricular conduction times according to cardiac-resynchronization therapy response.

Enrollment

100 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • meeting the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for cardiac-resynchronization (CRT) implant

Exclusion criteria

  • Myocardial infarction, unstable angina within 40 days prior the enrollment
  • Recent cardiac revascularization in the 4 weeks prior to the enrollment or planned for the 3 months following
  • Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months prior to the enrollment
  • Primary valvular disease requiring surgical correction
  • Pregnant or are planning during the duration of the investigation
  • Status 1 candidate for cardiac transplantation or consideration for transplantation over the next 12 months
  • Post-cardiac transplantation
  • Life expectancy < 12 months
  • Currently participating in any other clinical investigation except for observational registry

Trial design

100 participants in 2 patient groups

CRT responder
Treatment:
Diagnostic Test: Device interrogation
CRT non-responder
Treatment:
Diagnostic Test: Device interrogation

Trial contacts and locations

6

Loading...

Central trial contact

Seung-Jung Park

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems